Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 9,540 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: HEARTS Clear all

Conditions: Heart Failure Congestive
Interventions: Bumetanide, intranasal 4mg; Drug
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Acute Decompensated Heart Failure
Interventions: CD-NP; Drug
Lead sponsor: Nile Therapeutics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 10
States / cities: Los Angeles, California • Torrance, California • Jacksonville, Florida + 7 more

Conditions: Coagulation
Interventions: TTP889, Placebo; Drug
Lead sponsor: vTv Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 3
States / cities: New York, New York • Spokane, Washington

Conditions: Cardiovascular Disease
Interventions: Walking; Behavioral
Lead sponsor: Ernest Mazzaferri; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cardiovascular Disease
Interventions: Palm DAG Oil; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 30 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Heart Failure
Interventions: Tele-monitoring and health coaching; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 5
States / cities: Jacksonville, Florida • Mechanicsville, Virginia • Midlothian, Virginia + 2 more

Conditions: Carotid Atherosclerosis
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Congestive Heart Failure
Interventions: Beta blocker (carvedilol or metoprolol succinate), CRT (cardiac resynchronization therapy); Drug · Procedure
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: New York, New York • Rochester, New York • Philadelphia, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: High-Intensity Treadmill Training, Treadmill Training with Perturbations, Standard Treadmill Training; Procedure
Lead sponsor: Marquette University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Indianapolis, Indiana • Milwaukee, Wisconsin

Conditions: Feeding Disorders
Interventions: CHAMP Application; Device
Lead sponsor: Lori Erickson; Other
Eligibility: 1 Month to 6 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Acute Myocardial Infarction (AMI), Coronary Occlusion, Acute Coronary Syndrome
Interventions: Guardian System; Device
Lead sponsor: Angel Medical Systems; Industry
Eligibility: 21 Years and older
Enrollment: 1,020 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 95
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 85 more

Conditions: Ventricular Function
Interventions: three-dimensional echocardiography; Diagnostic Test
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Postoperative Cognitive Complications, Delirium, Perioperative/Postoperative Complications, Brain Injuries, Anesthesia
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Congenital Heart Disease in Children
Interventions: No intervention. It is observational; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 9
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Atlanta, Georgia + 6 more

Conditions: Cardiac Disease
Interventions: AI-Flex; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Atrial Fibrillation, Arterial Hypertension
Interventions: Redo PVI, PVI + RDN; Procedure
Lead sponsor: Meshalkin Research Institute of Pathology of Circulation; Network
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Complications; Cesarean Section, Anesthesia; Adverse Effect, Spinal and Epidural
Interventions: experimental, Control; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Patent hemostasis and heparin; Other
Lead sponsor: Olivier F. Bertrand; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Iron Deficiency (ID), Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction
Interventions: Notification Group, No Notification Group; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Sleep Quality
Interventions: Risk Stratification, Usual Care; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Atrial Fibrillation
Interventions: Amiodarone, Minocycline; Drug
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Melrose, Massachusetts

Conditions: Atrial Fibrillation
Interventions: Medtronic Cardiac Ablation System, Class I or III Antiarrhythmic Medications; Procedure · Drug
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 23
States / cities: Scottsdale, Arizona • Los Angeles, California • Jacksonville, Florida + 18 more

Conditions: Stroke
Interventions: Cardionet Mobile Cardiac Outpatient Telemetry (MCOT); Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)

Star-Close Early Ambulation Trial

Healthy Fatty Acids in Transition

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)

BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

CHAMP For the Feeder: Tube Feeding Study

AngelMed for Early Recognition and Treatment of STEMI

Assessment of Right Ventricular Volume in Pediatric Patients

The Genetic Basis of Atrial Fibrillation (AF)

Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery

Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures

A Study of a Multi-Modal Sensor Patch for Real-Time Physiological Monitoring and Inference

Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI

Non-invasive Cardiac Output Monitoring in Obstetric Patients

A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure

Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

Tailored Treatment of Permanent Atrial Fibrillation

Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS)